Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $21.9K | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $18.4K | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $20.7K | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $46.5K | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $19.4K | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $20.4K | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $20.4K | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $19.9K | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $19.8K | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $14.8K | SEC | |
ELITE PHARMACEUTICALS INC /NV/Listing on record | Award | $23.2K | SEC | |
AKORN INCListing unverified | Other | $9.3K | SEC | |
AKORN INCListing unverified | Other | $9.3K | SEC | |
AKORN INCListing unverified | Other | $50.3K | SEC | |
AKORN INCListing unverified | Sell | $42K | SEC | |
AKORN INCListing unverified | Sell | $7.8K | SEC | |
AKORN INCListing unverified | Sell | $12.6K | SEC | |
AKORN INCListing unverified | Sell | $16.6K | SEC | |
AKORN INCListing unverified | Sell | $694 | SEC | |
AKORN INCListing unverified | Sell | $27K | SEC | |
AKORN INCListing unverified | Other | $127.1K | SEC | |
AKORN INCListing unverified | AwardD (derivative) | — | SEC | |
AKORN INCListing unverified | Award | — | SEC | |
AKORN INCListing unverified | AwardD (derivative) | — | SEC | |
AKORN INCListing unverified | Other | $31.3K | SEC |